CD80 Rabbit Polyclonal Antibody
To Order Contact Us Below:
CD80 Rabbit pAb |
A16039-200ul |
Abclonal |
200 ul |
EUR 550.8 |
CD80 Rabbit pAb |
A16039-20ul |
Abclonal |
20 ul |
EUR 219.6 |
CD80 Rabbit pAb |
A16039-50ul |
Abclonal |
50 ul |
EUR 267.6 |
CD80 Rabbit mAb |
A19025-100ul |
Abclonal |
100 ul |
EUR 492 |
CD80 Rabbit mAb |
A19025-200ul |
Abclonal |
200 ul |
EUR 685.2 |
CD80 Rabbit mAb |
A19025-20ul |
Abclonal |
20 ul |
EUR 265.2 |
CD80 Rabbit mAb |
A19025-50ul |
Abclonal |
50 ul |
EUR 344.4 |
CD80 Antibody |
1-CSB-PA129040 |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000 |
CD80 Antibody |
1-CSB-PA130815 |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
CD80 Antibody |
1-CSB-PA277650 |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
CD80 Antibody |
1-CSB-PA004959GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
CD80 antibody |
70R-35657 |
Fitzgerald |
100 ug |
EUR 418.8 |
Description: Rabbit polyclonal CD80 antibody |
CD80 Antibody |
49409-100ul |
SAB |
100ul |
EUR 399.6 |
CD80 Antibody |
49409-50ul |
SAB |
50ul |
EUR 286.8 |
CD80 antibody |
70R-13908 |
Fitzgerald |
100 ug |
EUR 386.4 |
Description: Affinity purified Mouse polyclonal CD80 antibody |
CD80 Antibody |
37436-100ul |
SAB |
100ul |
EUR 302.4 |
CD80 antibody |
10R-6436 |
Fitzgerald |
100 ug |
EUR 282 |
Description: Armenian Hamster monoclonal CD80 antibody |
CD80 antibody |
10R-6437 |
Fitzgerald |
100 ug |
EUR 230.4 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-6844 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-7741 |
Fitzgerald |
500 ug |
EUR 678 |
Description: Rat monoclonal CD80 antibody |
CD80 antibody |
10R-1912 |
Fitzgerald |
100 ul |
EUR 483.6 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-CD80bMS |
Fitzgerald |
500 ug |
EUR 444 |
Description: Rat monoclonal CD80 antibody |
CD80 antibody |
10R-3627 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-3628 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-3629 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-3630 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-3631 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-3632 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-3634 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 antibody |
10R-3635 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal CD80 antibody |
CD80 Antibody |
8679-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody |
8679-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody |
V8234-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V8234-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V8234SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V8522-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
RQ6838 |
NSJ Bioreagents |
100ug |
EUR 419 |
Description: Cluster of Differentiation 80 (also CD80 and B7-1) is a protein found on activated B cells and monocytes that provides a costimulatory signal necessary for T cell activation and survival. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. The CD80 genes encode B7-1 which are structurally similar members of the immunoglobulin superfamily expressed on a variety of hematopoietic cell types. |
CD80 Antibody |
V7382-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V7382-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V7382IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V7382SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V7498-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V7498-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V7498SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V3297-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V3297-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V3297SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V8522-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
CD80 Antibody |
V8522SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell. |
Polyclonal CD80 Antibody (internal region) |
APR11032G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human CD80 (internal region). This antibody is tested and proven to work in the following applications: |
Rabbit T- lymphocyte activation antigen CD80, CD80 ELISA KIT |
ELI-06510Ra |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Anti-CD80/B7 1 Rabbit Monoclonal Antibody |
M00196 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal CD80/B7 1 Antibody. Validated in IHC, WB and tested in Human. |
Polyclonal CD80 antibody - C-terminal region |
APR11033G |
Leading Biology |
0.05mg |
EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD80 - C-terminal region. This antibody is tested and proven to work in the following applications: |
T-lymphocyte activation antigen CD80 (CD80) Antibody |
20-abx019054 |
Abbexa |
|
|
|
CD80 Conjugated Antibody |
C49409 |
SAB |
100ul |
EUR 476.4 |
anti- CD80 antibody |
FNab01500 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against CD80 |
CD80 antibody (FITC) |
61R-1108 |
Fitzgerald |
100 ug |
EUR 360 |
Description: Armenian Hamster monoclonal CD80 antibody (FITC) |
CD80 antibody (PE) |
61R-1274 |
Fitzgerald |
100 ug |
EUR 379.2 |
Description: Mouse monoclonal CD80 antibody (PE) |
CD80 antibody (PE) |
61R-1275 |
Fitzgerald |
100 ug |
EUR 424.8 |
Description: Armenian Hamster monoclonal CD80 antibody (PE) |
CD80 antibody (PE) |
61R-1276 |
Fitzgerald |
100 tests |
EUR 463.2 |
Description: Mouse monoclonal CD80 antibody (PE) |
CD80 antibody (biotin) |
61R-1527 |
Fitzgerald |
100 ug |
EUR 379.2 |
Description: Mouse monoclonal CD80 antibody (biotin) |
CD80 antibody (biotin) |
61R-1528 |
Fitzgerald |
100 ug |
EUR 340.8 |
Description: Armenian Hamster monoclonal CD80 antibody (biotin) |
CD80 antibody (biotin) |
61R-1529 |
Fitzgerald |
100 ug |
EUR 379.2 |
Description: Mouse monoclonal CD80 antibody (biotin) |
CD80 antibody (allophycocyanin) |
61R-1743 |
Fitzgerald |
100 ug |
EUR 548.4 |
Description: Armenian Hamster monoclonal CD80 antibody (allophycocyanin) |
CD80 antibody (FITC) |
61R-CD80bHUFT |
Fitzgerald |
120 tests |
EUR 651.6 |
Description: Mouse monoclonal CD80 antibody (FITC) |
CD80 antibody (Allophycocyanin) |
61R-CD80bMSAPC |
Fitzgerald |
100 ug |
EUR 522 |
Description: Rat monoclonal CD80 antibody (Allophycocyanin) |
CD80 antibody (biotin) |
61R-CD80bMSBT |
Fitzgerald |
500 ug |
EUR 495.6 |
Description: Rat monoclonal CD80 antibody (biotin) |
CD80 antibody (FITC) |
61R-CD80bMSFT |
Fitzgerald |
500 ug |
EUR 548.4 |
Description: Rat monoclonal CD80 antibody (FITC) |
CD80 antibody (PE) |
61R-CD80bMSPE |
Fitzgerald |
200 ug |
EUR 548.4 |
Description: Rat monoclonal CD80 antibody (PE) |
Hamster CD80 Antibody |
abx140014-01mg |
Abbexa |
0.1 mg |
EUR 343.2 |
|
Anti-CD80 Antibody |
A00196-1 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-CD80 Antibody |
PA1365 |
BosterBio |
100ug/vial |
EUR 352.8 |
Anti-CD80 Antibody |
PA1365-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
anti- CD80 antibody |
FNab09813 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against CD80 |
Anti-CD80 antibody |
STJ170002 |
St John's Laboratory |
100 µg |
EUR 409.2 |
Description: The CD80 antigen (B7, BB1) recognizes a 60 kDa transmembrane glycoprotein, member of the immunoglobulin family. This molecule shares with CD86 the capability to be the ligand for two structurally similar molecules expressed on T lymphocytes, CD28 and CD152 (CTLA-4). CD80 antigen is expressed on in vitro activated B lymphocytes. It is not expressed on the majority of resting B cells from peripheral blood but identifies a subpopulation of B cells that has been previously activated. The antigen is also expressed by HTLV-1 transformed T cells activated monocytes, and constitutively on dendritic cells. CD80 binding provides costimulatory signals for T cell activation. |
CD80 Antibody [8G12] |
RF16041-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [8G12] |
RF16041-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [10A1] |
RF16042-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [10A1] |
RF16042-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [7A2] |
RF16043-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [7A2] |
RF16043-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [11D1] |
RF16044-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [11D1] |
RF16044-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [11C12] |
RF16045-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [11C12] |
RF16045-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [12D9] |
RF16046-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
CD80 Antibody [12D9] |
RF16046-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2). |
Anti-CD80 antibody |
STJ98977 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to CD80. |
Anti-CD80 antibody |
STJ97938 |
St John's Laboratory |
100 µl |
EUR 280.8 |
Description: Mouse monoclonal to CD80. |
CD80 Rabbit Polyclonal Antibody